ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0071

Significant Enrichment of Transcriptionally Distinct CD206+CD163+ Macrophage Population in Rheumatoid Arthritis Synovial Tissue

Megan Hanlon1, Mary Canavan2, Qingxuan Song3, Candice Low4, Phil Gallagher5, Ronan Mullan6, Conor Hurson7, Sunil Nagpal8, Douglas Veale9 and Ursula Fearon2, 1Molecular Rheumatology, Trinity College Dublin, Dublin 2, Dublin, Ireland, 2Molecular Rheumatology, Trinity College Dublin, Dublin, Dublin, Ireland, 3Janssen Research & Development, LLC, Spring House, PA, USA, Spring House, PA, 4EULAR Centre for Arthritis and Rheumatic diseases, St Vincents University Hospital, UCD, Dublin, Ireland, 5St Vincents University Hospital, UCD, Dublin, Ireland, 6Adelaide and Meath Hospital, Dublin, Dublin, Ireland, 7St Vincents University Hospital, UCD, Dublin, Dublin, Ireland, 8Janssen Research & Development, Collegeville, PA, 9EULAR Centre for Arthritis and Rheumatic Diseases, St Vincents University Hospital, UCD, Dublin, Dublin, Ireland

Meeting: ACR Convergence 2020

Keywords: immunology, macrophages, rheumatoid arthritis

  • Tweet
  • Email
  • Print
Session Information

Date: Friday, November 6, 2020

Title: Innate Immunity Poster

Session Type: Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Synovial tissue macrophages are an exquisitely plastic pool of innate cells that play a key role in RA disease progression. However, the precise nature, diversity and function of macrophage subsets within the inflamed joint remains unexplored.

Methods: Single cell analysis of Rheumatoid Arthritis, Psoriatic Arthritis, Osteoarthritis and healthy control synovial tissue biopsies and synovial fluid mononuclear cells was performed using advanced flow cytometry with the following panel (CD40, CD45, CD64, CD68, CD163, CD206, CD253, CCR4, CCR7, CXCR1, CXCR3). CD206+CD163+ and CD206-CD163- macrophages were sorted from RA synovial tissue by FACSAria sorter for subsequent RNAseq, FLIM analysis and autologous T-cell co-culture experiments.

Results: RA synovial tissue and fluid macrophages display markers typical of both M1 (CD40+CD253+) and M2 (CD206+CD163+) macrophages with a spectrum of macrophage activation states identified in RA synovial tissue that don’t fully conform to the classic M1/M2 framework. Within this spectrum, significant enrichment of a dominant CD206+CD163+ macrophage-subtype is present in synovial tissue versus fluid (p< 0.05). CD206+CD163+ synovial tissue macrophages express significantly more CD40 compared to synovial fluid (p< 0.0003), positively correlate with disease activity (r=0.6, p< 0.01), with baseline levels predicting response to therapy (p< 0.05). Moreover, CD206+CD163+CD40+ macrophages are enriched in RA synovial tissue compared to PsA and OA pathotypes (p< 0.05) and display distinct chemokine receptor expression patterns. While the CD206+CD163+ macrophage subset is present in healthy synovial tissue, expression of CD40 is completely absent in the healthy synovium (p< 0.05). RNA-seq analysis indicates that the CD206+CD163+ population is transcriptionally distinct from synovial tissue CD206-CD163-, synovial fluid CD206+CD163+, and pure RA monocyte-derived M1/M2 macrophages, with unique tissue-resident gene signatures (TREM2+, FOLR2+, LYVE1+ C1QA+, TIMD4+, CD48-, CCR2-). Moreover, differing metabolic demands between CD206+CD163+ and CD206-CD163- subsets was demonstrated by RNAseq and FLIM analysis. Finally, CD206+CD163+ macrophages have the capacity to induce autologous T-cell responses and spontaneously secrete high levels of pro-inflammatory cytokines, thus further contributing to the local inflammatory response.

Conclusion: This data identifies enrichment of a previously undescribed dysfunctional dominant and transcriptionally distinct macrophage subtype in RA synovial-tissue.


Disclosure: M. Hanlon, None; M. Canavan, None; Q. Song, Janssen Research & Development, LLC, Spring House, PA, USA, 3; C. Low, None; P. Gallagher, None; R. Mullan, None; C. Hurson, None; S. Nagpal, None; D. Veale, AbbVie, 2, Health Beacon, 1, Janssen, 2, 8, Pfizer, 2, 5, 8, Novartis, 2, 5, 8, UCB, 2, 5; U. Fearon, None.

To cite this abstract in AMA style:

Hanlon M, Canavan M, Song Q, Low C, Gallagher P, Mullan R, Hurson C, Nagpal S, Veale D, Fearon U. Significant Enrichment of Transcriptionally Distinct CD206+CD163+ Macrophage Population in Rheumatoid Arthritis Synovial Tissue [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/significant-enrichment-of-transcriptionally-distinct-cd206cd163-macrophage-population-in-rheumatoid-arthritis-synovial-tissue/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/significant-enrichment-of-transcriptionally-distinct-cd206cd163-macrophage-population-in-rheumatoid-arthritis-synovial-tissue/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology